Notice of alternative medication authorization, November 25, 2021
Legal publications
Updated on
21 December 2021
This notice was published on December 21, 2021.
Medroxyprogesterone acetate (2.5 mg) replaces:
- Apo-Medroxy
- Novo-Medrone
Related topics